Pharmaceutical composition
US6476004B1 · kind B1 · utility
23Cited by
5References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 1999 |
| Grant date | Nov 5, 2002 |
| Priority date | — |
| Expiry date | Jan 14, 2019 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB82Y5/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Medicinal compositions which can be processed into solutions and are useful in inhibiting rejection reactions against the transplantation of organs or bone marrow, in the maintenance immunotherapy therefor or in treating autoimmune diseases, characterized by containing 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol or pharmaceutically acceptable acid-addition salts thereof and cyclodextrins as a stabilizer optionally together with saccharides, if required.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.